TITLE:
Rotavirus Efficacy and Safety Trial (REST)(V260-006)

CONDITION:
Rotavirus Infections

INTERVENTION:
Rotateq

SUMMARY:

      This study was designed to evaluate the safety of the investigational rotavirus vaccine and
      the efficacy to prevent rotavirus gastroenteritis.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 6 Weeks to 12 Weeks
Criteria:

        Inclusion Criteria:

          -  Healthy infants

        Exclusion Criteria:

          -  None Specified
      
